COPENHAGEN, Feb 9 (Reuters) – Novo Nordisk said on Monday it has filed a lawsuit against U.S. telehealth company Hims & Hers for infringing on the Danish group’s patents.
“Novo Nordisk is asking the court to permanently ban Hims from selling unapproved, compounded drugs that infringe our patents, and is seeking to recover damages,” the Danish drugmaker said in a statement.
The move comes after Hims on Saturday cancelled the launch of a $49 copy of a weight-loss pill following legal threats from Novo Nordisk and the U.S. Food and Drug Administration.
(Reporting by Stine Jacobsen, editing by Terje Solsvik)
